Exforge

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2007-2016
01220072016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
  • Nature Biotechnology
  • 2016
IDegLira and iGlarLixi are the first fixeddose combinations to contain long-acting insulin in the formulations. These once-a day… (More)
Is this relevant?
2014
2014
BACKGROUND AND OBJECTIVE Valsartan, an angiotensin receptor blocker, is often used with calcium channel blockers (CCBs) such as… (More)
Is this relevant?
Review
2014
Review
2014
Health care providers managing hypertension (HTN) have a large selection of pharmacologic agents to choose from, including… (More)
Is this relevant?
2013
2013
AIM To collect information on the efficiency and safety of a fixed-dose combination of amlodipine/valsartan in patients who… (More)
Is this relevant?
2013
2013
Catheter-Based Renal Nerve Ablation and Centrally Generated Sympathetic Activity in Difficult-to-Control Hypertensive Patients To… (More)
Is this relevant?
2009
2009
BACKGROUND Both diastolic dysfunction and increased vascular stiffness represent important measures of target-organ damage in… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Review
2009
Review
2009
Single-pill combinations of the dihydropyridine calcium channel blocker (CCB) amlodipine and the angiotensin II receptor blocker… (More)
  • table I
  • table II
  • table III
  • table V
  • figure 1
Is this relevant?
Review
2007
Review
2007
Hypertension is a common treatable risk factor for cardiovascular disease. Even when identified and treated, most patients with… (More)
Is this relevant?